Cardio Diagnostics Holdings, Inc.
CDIOW- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $139.7K in total; no superinvestor holds it.
Other share classesCDIO
Q3 2023 vs. Q2 2023
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 1.27M | 1.26M | −11.6K (−0.9%) |
| Value | $222.7K | $45.4K | −$177.3K (−79.6%) |
New holders (1)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 147 | $5 | 0.00% |
Sold out (1)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Castle Creek Arbitrage, LLC | 11,710 | $1.89K |